[BXRX] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[BXRX] Baudax Bio, Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 41.21%
YoY- 50.87%
Quarter Report
BXRX's Result
BXRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
Revenue 30 300 201 349 0 -
PBT -7,301 -7,531 -15,329 -30,445 -10,582 -8.85%
Tax 3,086 559 3,822 16,720 -4,059 -
NP -7,375 -7,531 -15,329 -30,445 -10,582 -8.62%
Tax Rate - - - - - -
Total Cost 7,405 7,831 15,530 30,794 10,582 -8.53%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
NP Margin -24,583.33 -2,510.33 -7,626.37 -8,723.50 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
EPS -1.51 -41.95 -286.80 -2,408.04 -1,632.02 -82.53%
EPS Diluted -1.51 -41.95 -287.20 -2,408.04 -1,632.02 -82.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.